Nicholas D. Kindon

Antagonists of the Platelet P<i>_2T</i> Receptor:  A Novel Approach to Antithrombotic Therapy

Anthony H. Ingall, John Dixon, Andrew Bailey et al. · Journal of Medicinal Chemistry · 1999 · 285 citations

Antithrombotic Therapy, Novel Approach, Pharmacotherapy +17

2-Ene-1,4-diols by Dimerization of Terminal Epoxides using Hindered Lithium Amides

David M. Hodgson, Christopher D. Bray, Nicholas D. Kindon · Organic Letters · 2005 · 56 citations

Enamines from Terminal Epoxides and Hindered Lithium Amides

David M. Hodgson, Christopher D. Bray, Nicholas D. Kindon · Journal of the American Chemical Society · 2004 · 56 citations

Engineering, Alkene Metathesis, Organic Chemistry +10

Diastereomer-dependent substrate reduction properties of a dinitrogenase containing 1-fluorohomocitrate in the iron-molybdenum cofactor.

Mark Madden, Nicholas D. Kindon, Paul W. Ludden et al. · Proceedings of the National Academy of Sciences · 1990 · 51 citations · Full text

Inorganic Chemistry, Biosynthesis, Engineering +14

Pharmacological profile of the novel P₂T‐purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivo

Robert G. Humphries, Wendy Tomlinson, J. A. Clegg et al. · British Journal of Pharmacology · 1995 · 49 citations · Full text

Fold Selectivity, Neuropeptides, Fpl 67085 +19